Juvenile psammomatoid ossifying fibroma of the maxilla and mandible: A systematic review of published case reports

Abstract

Objective: The aim of this study is to evaluate recent evidence-based data that summarize the clinicopathological findings and treatment along with follow-up measures taken in terms of published cases of Juvenile psammomatoid ossifying fibroma (JPOF) of the maxilla and mandible by a systematic review. Materials and Methods:The databases searched were PubMed, MEDLINE, Scopus, Google scholar, and Cross references. Only those case reports of JPOFs published in the English language from 2000 to 2022 were considered. All cases included confirmed JPOF lesions histopathologically. The SR-included details like clinical and radiographic data, follow-up details such as recurrence, and the presence of any adverse outcome. Results:The database search produced 595 articles from 2000 to 2022, among which 22 case reports were included in the systematic review. The mean age of JPOF occurrence in patients was 18 ± 16 years. A male predilection was noted among patients younger than 14 years of age, whereas a female predilection was noted in patients older than 14 years of age. Frequent involvement of the mandible (56%) compared to the maxilla (44%) was reported. The posterior mandible was the most commonly affected site involving numerous adjacent structures. The expansile nature of the JPOF displayed 57% buccolingual expansion, 50% downward displacement or erosion of the lower border of the mandible and 81% of involvement of the maxillary antrum/pterygoid plate/orbital floor. Among the 20 cases reported, the treatment provided included surgical excision in 45% of the patients, jaw resection in 35% of the patients, and enucleation and curettage in 18% of the patients. Follow-up details were provided in 80% of the reports that showed recurrence. Conclusions:The diagnosis of JPOF requires correlation of the clinical and radiographic features with key histopathological features. Although long-term

Sturge-Weber syndrome with cemento-ossifying fibroma in the maxilla and giant odontoma in the mandible: A case report

“…There have been no reports of malignant transformation; however, the recurrence rate is high (approximately 30%–58 %). Since local invasiveness is observed, complete removal is recommended; however, curettage, excision, or partial resection may also be selected depending on the site and the individual patient's condition [ 12 , 13 ]. In contrast, COF, which was the final diagnosis, is a benign odontogenic mesenchymal tumor arising in the tooth-bearing area of the jawbone.…”